TORONTO, May 5 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP), a biopharmaceutical company dedicated in the research, development and commercialization of pharmaceutical products and technologies for the management of cancer, announced today that it has strengthened its senior management team with the appointment of Dr. Saeid Babaei to Vice-President of Business Development and Dr. Yoon Lee to Vice-President of Research. Both will serve as members of Lorus' senior management team.
Dr. Babaei joined Lorus in 2006, where he has held the progressive positions of Associate Director of Corporate Affairs and Director of Corporate Development, and has played a key role in a broad range of activities involving investor relations, business development and licensing strategies. As Vice-President of Business Development, Dr. Babaei will have responsibilities in planning, developing and implementing Lorus' business development efforts and strategic partnerships. His multi-disciplinary experience spans over fifteen years in the biotechnology and healthcare sectors, during which he has negotiated strategic alliances and licensing deals, established joint ventures and assisted in private financings to support product development. Dr. Babaei received a PhD and an executive MBA, both from the University of Toronto. He has authored many scientific publications, patents and conference proceedings. He currently serves as a member of the Board of Directors for several not-for-profit organizations.
Dr. Lee has been with Lorus for ten years, most recently serving as the
Director of Research. He has been responsible for overseeing research
discovery and product development programs, including anticancer
immunomodulators, DNA/RNA-based therapeutics and small molecules. As Vice-
President of Research, Dr. Lee will be responsible for developing and
implementing the scientific direction of Lorus. Dr. Lee received his Ph.D.
degree in Molecu
|SOURCE Lorus Therapeutics Inc.|
Copyright©2008 PR Newswire.
All rights reserved